Literature DB >> 18440771

Methadone: to ECG or not to ECG...That is still the question.

Ricardo A Cruciani1.   

Abstract

There is significant controversy about the potential deleterious effect of methadone on cardiac conduction. Although several reports suggest that patients receiving methadone are at increased risk for QTc prolongation and torsade de pointes, a potentially fatal arrhythmia, others have not replicated these findings. Hence, it is not surprising that there is no consensus on when to perform an electrocardiogram, a simple test to assess the QTc interval, during methadone therapy. Most of the uncertainty is generated by the lack of large controlled studies. This review presents the current data on this issue in an effort to help in the decision-making process until more conclusive data become available.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440771     DOI: 10.1016/j.jpainsymman.2007.11.003

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  18 in total

1.  Methadone-Associated Prolongation of the QTc Interval at Doses Used for Chronic Pain.

Authors:  James K McNamara; Nataliya Shinkazh; Fay Rim; Remy Sunga; Adrian Cristian
Journal:  P T       Date:  2011-02

2.  Changes of QTc interval after opioid switching to oral methadone.

Authors:  Sebastiano Mercadante; Giovanna Prestia; Claudio Adile; Alessandra Casuccio
Journal:  Support Care Cancer       Date:  2013-08-15       Impact factor: 3.603

Review 3.  Methadone, QTc prolongation and torsades de pointes: Current concepts, management and a hidden twist in the tale?

Authors:  Sobia Mujtaba; Jorge Romero; Cynthia C Taub
Journal:  J Cardiovasc Dis Res       Date:  2013-11-16

4.  Update in hospice and palliative care.

Authors:  Wendy G Anderson; Nathan E Goldstein
Journal:  J Palliat Med       Date:  2010-02       Impact factor: 2.947

5.  [ECG changes in patients with chronic non-cancer pain: a prospective observational study].

Authors:  V Peuckmann-Post; R Eickhoff; M Becker; D von der Laage
Journal:  Schmerz       Date:  2012-08       Impact factor: 1.107

6.  QTc interval screening in an opioid treatment program.

Authors:  David F Katz; Jun Sun; Vaishali Khatri; David Kao; Becki Bucher-Bartelson; Carol Traut; John Lundin-Martinez; Michael Goodman; Philip S Mehler; Mori J Krantz
Journal:  Am J Cardiol       Date:  2013-06-29       Impact factor: 2.778

Review 7.  Methadone deaths: risk factors in pain and addicted populations.

Authors:  Vania Modesto-Lowe; Donna Brooks; Nancy Petry
Journal:  J Gen Intern Med       Date:  2010-01-20       Impact factor: 5.128

8.  Trends in reporting methadone-associated cardiac arrhythmia, 1997-2011: an analysis of registry data.

Authors:  David Kao; Becki Bucher Bartelson; Vaishali Khatri; Richard Dart; Philip S Mehler; David Katz; Mori J Krantz
Journal:  Ann Intern Med       Date:  2013-05-21       Impact factor: 25.391

Review 9.  How to Use Methadone in an Era of an Opioid Epidemic.

Authors:  Yvonne Heung; Akhila Reddy
Journal:  Curr Treat Options Oncol       Date:  2020-03-19

10.  The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study.

Authors:  Suresh Reddy; David Hui; Badi El Osta; Maxine de la Cruz; Paul Walker; J Lynn Palmer; Eduardo Bruera
Journal:  J Palliat Med       Date:  2010-01       Impact factor: 2.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.